8-K filing — AECOM (ACM)
Filed: 2026-09-16 AccNo: 0001104659-26-108255 Size: 190 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Stocks · News reference
S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone
U.S. stocks closed higher, with Nasdaq up 300 points. S&P 500 and Nasdaq rose for the second consecutive week. Fear & Greed index in Greed zone.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
AECOM, Jaccobc JV Appointed As Program Delivery Partner For MetroLink By Transport Infrastructure Ireland
An AECOM (NYSE: ACM) and Jacobs joint venture has been appointed by Transport Infrastructure Ireland (TII) as Program Delivery Partner for MetroLink, a transformative transportation program that will provide a
Can Quanta's $53B Backlog Keep Its Infrastructure Boom Alive?
Quanta Services (PWR) reported strong Q2 2026 performance with a record $53B backlog, up from $48.5B in Q1. The company raised full-year 2026 revenue guidance to $39.3-$39.7B and adjusted EPS to $16.45-$16.95. Recent acquisitions are expected to add $1.2-$1.4B in revenues and $120-$140M in EBITDA. PWR stock has gained 51.4% year-to-date and currently holds a Zacks Rank #1 (Strong Buy) rating.
Raoul Pal Says There’s ‘Almost No Way’ AI Data Centers Don’t Trigger a Supercycle — 3 Stocks Positioned to Benefit
Data centers are being built at less than a third of the pace the AI race demands, says macro investor Raoul Pal.
Needham Reiterates Buy on Alcon, Maintains $98 Price Target
Needham analyst David Saxon reiterates Alcon (NYSE:ALC) with a Buy and maintains $98 price target.
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from the President to deliver.